Recorded 2022 LIVE @ LUNCH -New Drug Update
LIVE @ LUNCH - New Drug Update webinar is part of our LIVE @ LUNCH Webinar Subscription. There are five 1-hour courses included in this webinar series and each can be purchased separately for $25 each. If you are interested in signing up for the $100 webinar subscription for all 5 LIVE @ LUNCH programs, you may do so by clicking on the following link below and will receive a code to register for any/all webinars.
LIVE @ LUNCH subscription for $100 includes:
- May 25 from 12-1pm
- June 8th 12-1pm
- August 24th from 12-1pm
- October 5th from 12-1pm
- December 7 from 12-1pm
By continuing here and registering, you are signed up for only this LIVE @ LUNCH -New Drug Update CE program and NOT the subscription of 5 courses.
Technology Requirements - Computer and Internet access is required to complete this activity.
This knowledge-based program is intended for Pharmacists, Pharmacy Technicians, and Nurses.
1) Describe the therapeutic indication and clinical profile
2) Recognize the dosage form and route of administration
3) Describe the mechanism of drug action
4) Identify factors that limit drug use (contraindications, precautions and adverse effects)
5) Describe potentially significant drug interactions
The presentation will provide an update on new drugs approved by the FDA over the past calendar year.
A copy of the presentation slides are located within the course content. Once you have registered for the course, please navigate to the 'Take Course' tab and click the navy blue 'Take Course' button. Navigate to the 'Course Materials' section of the course using the left-hand menu and download a PDF version of the program presentation. Course Materials will be added to the course the week of the live event.
Jack DeRuiter was born in Holland, Michigan where he earned a bachelor’s degree in Chemistry and Biology from Hope College in 1976. From 1976-1978 he attended the University of Michigan completing a Master’s degree in Medicinal Chemistry where he worked on the design of novel anti-parasitic quinolone drugs. From there Dr. DeRuiter went to the Medical College of Virginia at Virginia Commonwealth University in Richmond where he earned a PhD in 1981 in the area of neuro-medicinal chemistry. His PhD research involved the design and testing of structurally unique adrenergic receptor probes. In 1981 Dr. DeRuiter accepted a post-doctoral position at the State University of New York at Buffalo where he investigated the design and synthesis of novel potential anti-cancer drugs of the pyrroloquinoline class. In 1983 he joined the faculty at Auburn University’s Harrison College of Pharmacy as an Assistant Professor and member of the Graduate Faculty. He was promoted to Associate professor with tenure in 1988, and to full Professor in 1993. Dr. DeRuiter’s primary responsibilities at Auburn University have been curricular design and development, teaching in the professional and graduate programs and conducting research. In his 30+ years at Auburn Dr. DeRuiter has been engaged in a number of research projects, with a major focus on drug design methods in the areas of diabetes, cancer and novel psychoactive agents. His research team has received over 10 million dollars in federal research funding, and he and his colleagues have published over 200 peer-reviewed research articles, 150 professional articles and book chapters and 20 technical manuals. Dr. DeRuiter and his students also have given more than 150 presentations at scientific meetings across the globe. Dr. DeRuiter was named Hill Crest Endowed Professor in 2019, and Alumni Professor in 2021. He also serves a medical consultant for several law firms throughout the southeast and as an educational consultant focusing on curricular design, development and integration of basic and clinical science content.
Auburn University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education; credits are recognized nationwide. The Universal Activity Number for this knowledge-based program is 0001-0000-22-076-H01-P/T and is intended for pharmacists and pharmacy technicians. The initial release date for this recorded program is November 1, 2022 and the intended expiration date is November 1, 2025.
Auburn University Harrison School of Pharmacy is a Board approved provider of continuing nursing education in Alabama by the Alabama Board of Nursing. Provider Number: ABNP1515.
- 1.20 ABNAuburn University Harrison School of Pharmacy is a Board approved provider of continuing nursing education in Alabama by the Alabama Board of Nursing. Provider Number: ABNP1515
- 1.00 ACPE PharmacyAuburn University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education; credits are recognized nationwide.
- 1.00 ACPE TechnicianAuburn University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education; credits are recognized nationwide.
Please click ADD TO Cart. You will be directed to your shopping cart for check out or you can proceed to check out by clicking on the shopping cart icon at the top right of your screen.
If you have a COUPON CODE, it can be applied on the shopping cart page or the CHECKOUT page. Please click APPLY TO ORDER.
Proceed to CHECKOUT and fill in your information. Choose your payment method and REVIEW ORDER.
You will be directed to our payment system to complete your order. An order confirmation email will be sent to your email address on file.
Once your order is complete, you will now have access to the course materials. Return to the course page and click TAKE COURSE to proceed.